Elizabeth Willis
Nurse Practitioner · Shreveport, LANPI 1083817969
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,799 of the $6,549 with a category attached, or 88.5%. It is spread thinly across 18 manufacturers, the largest accounting for just 22.4% — the pattern of someone who eats at a lot of different presentations. Among nurse practitioner clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 246 payments — averaging $26.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Cvrx, Inc.$1K
- Boehringer Ingelheim$569
- Novartis$542
- Merck$436
- E.r. Squibb & Sons, L.L.C.$402
- plus $2K from 12 others
What the payments were for
- Travel & lodging$73611%
- Food & beverage$5,79989%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 53 | $1,468 |
| Cvrx, Inc. | 13 | $1,382 |
| Boehringer Ingelheim | 26 | $569 |
| Novartis | 48 | $542 |
| Merck | 24 | $436 |
| E.r. Squibb & Sons, L.L.C. | 10 | $402 |
| Pfizer | 22 | $399 |
| Abbott | 5 | $252 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 19 | $241 |
| Lexicon Pharmaceuticals, Inc. | 2 | $152 |
| Itamar Medical Inc | 2 | $145 |
| Novo Nordisk | 2 | $143 |
| Kestra Medical Technology Services, Inc. | 5 | $128 |
| Bayer | 5 | $93 |
| Daiichi Sankyo Inc. | 3 | $71 |
| Alnylam Pharmaceuticals Inc. | 4 | $66 |
| Bridgebio Pharma, Inc. | 2 | $45 |
| Amgen | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Barostim Neo System$856
- FARXIGA$375
- LOKELMA$236
- WatchPATONE$133
- JARDIANCE$125
- CAMZYOS$125
- Inpefa$125
- CardioMEMS HF System$120
How this compares
$6,549 in reported general payments places this provider in the 90th percentile of 969 nurse practitioner providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VyndamaxTafamidis | 15 | $368,212 |
| EntrestoSacubitril/Valsartan | 417 | $351,337 |
| JardianceEmpagliflozin | 224 | $167,192 |
| FarxigaDapagliflozin Propanediol | 255 | $165,950 |
| EliquisApixaban | 152 | $94,790 |
| VerquvoVericiguat | 15 | $15,460 |
| XareltoRivaroxaban | 13 | $12,780 |
| CorlanorIvabradine Hcl | 14 | $9,294 |
| Bumetanide | 374 | $8,764 |
| DapagliflozinDapagliflozin Propanediol | 17 | $7,835 |
| Potassium Chloride | 382 | $4,536 |
| Metoprolol Succinate | 331 | $3,278 |
| Spironolactone | 479 | $2,709 |
| Digoxin | 132 | $1,418 |
| Furosemide | 367 | $1,316 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerVyndamax, Eliquis | $399 | $463,002167 claims |
| NovartisEntresto | $542 | $351,337417 claims |
| Boehringer IngelheimJardiance | $569 | $167,192224 claims |
| AstraZenecaFarxiga | $1,468 | $165,950255 claims |
| MerckVerquvo | $436 | $15,46015 claims |
| AmgenCorlanor | $14 | $9,29414 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 969 nurse practitioner providers in Louisiana.
Other nurse practitioner in Shreveport
- Tammy BennettShreveport$99K
- Sara BlankenshipShreveport$12K
- Gina InthavongShreveport$12K
- Valerie ScottShreveport$9K
- Amanda FosterShreveport$9K
- Deanna KamphuisShreveport$8K
- Amy LewingShreveport$7K
- Theresa StewartShreveport$7K
- Jacquline JansenShreveport$6K
- James HarrisShreveport$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.